These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22331092)

  • 1. Bladder cancer: validity of the 2004 system for grading Ta bladder cancer.
    Burger M; Goebell PJ
    Nat Rev Urol; 2012 Feb; 9(3):126-7. PubMed ID: 22331092
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review.
    Soukup V; Čapoun O; Cohen D; Hernández V; Babjuk M; Burger M; Compérat E; Gontero P; Lam T; MacLennan S; Mostafid AH; Palou J; van Rhijn BWG; Rouprêt M; Shariat SF; Sylvester R; Yuan Y; Zigeuner R
    Eur Urol; 2017 Nov; 72(5):801-813. PubMed ID: 28457661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bladder cancer: Active surveillance for low-grade Ta bladder tumours.
    Soloway MS
    Nat Rev Urol; 2016 Jun; 13(6):303-4. PubMed ID: 26878804
    [No Abstract]   [Full Text] [Related]  

  • 4. Grading Noninvasive Bladder Cancer: World Health Organisation 1973 or 2004 May Be the Wrong Question.
    Varma M; Delahunt B; van der Kwast T
    Eur Urol; 2019 Oct; 76(4):413-415. PubMed ID: 31080126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of being grade 3: WHO 1999 versus WHO 2004 pathologic grading.
    Liedberg F; Lauss M; Patschan O; Aine M; Chebil G; Cwikiel M; Engilbertsson H; Gudjonsson S; Kollberg P; Sjödahl G; Månsson W; Lindgren D; Höglund M;
    Eur Urol; 2012 Oct; 62(4):620-3. PubMed ID: 22698575
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
    Chang WC; Chang YH; Pan CC
    Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value and reproducibility of different microscopic characteristics in the WHO grading systems for pTa and pT1 urinary bladder urothelial carcinomas.
    Kvikstad V; Mangrud OM; Gudlaugsson E; Dalen I; Espeland H; Baak JPA; Janssen EAM
    Diagn Pathol; 2019 Aug; 14(1):90. PubMed ID: 31412916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review.
    Cumberbatch MGK; Foerster B; Catto JWF; Kamat AM; Kassouf W; Jubber I; Shariat SF; Sylvester RJ; Gontero P
    Eur Urol; 2018 Jun; 73(6):925-933. PubMed ID: 29523366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary Grading and Staging of Urothelial Neoplasms of the Urinary Bladder: New Concepts and Approaches to Challenging Scenarios.
    Gallan AJ; Choy B; Paner GP
    Surg Pathol Clin; 2018 Dec; 11(4):775-795. PubMed ID: 30447841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of 2004 ISUP/WHO classification on bladder cancer grading.
    Lokeshwar SD; Ruiz-Cordero R; Hupe MC; Jorda M; Soloway MS
    World J Urol; 2015 Dec; 33(12):1929-36. PubMed ID: 25833661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updates in Histologic Grading of Urologic Neoplasms.
    Rice-Stitt T; Valencia-Guerrero A; Cornejo KM; Wu CL
    Arch Pathol Lab Med; 2020 Mar; 144(3):335-343. PubMed ID: 32101058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active Surveillance or Office Fulguration for Low Grade Ta Bladder Tumors: A Win-Win for Patients and Urologists.
    Soloway MS
    J Urol; 2018 May; 199(5):1120-1122. PubMed ID: 28987859
    [No Abstract]   [Full Text] [Related]  

  • 13. Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series.
    Gendy R; Delprado W; Brenner P; Brooks A; Coombes G; Cozzi P; Nash P; Patel MI
    BJU Int; 2016 Apr; 117 Suppl 4():54-9. PubMed ID: 26486968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [II. Urothelial carcinoma-current topics and treatment for non-muscle invasive bladder cancer-].
    Kikuchi E; Oya M
    Gan To Kagaku Ryoho; 2014 Jan; 41(1):42-6. PubMed ID: 24796021
    [No Abstract]   [Full Text] [Related]  

  • 15. The clinical significance of a second transurethral resection for T1 high-grade bladder cancer: Results of a prospective study.
    Shim JS; Choi H; Noh TI; Tae JH; Yoon SG; Kang SH; Bae JH; Park HS; Park JY
    Korean J Urol; 2015 Jun; 56(6):429-34. PubMed ID: 26078839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the bladder.
    Burger M; Oosterlinck W; Konety B; Chang S; Gudjonsson S; Pruthi R; Soloway M; Solsona E; Sved P; Babjuk M; Brausi MA; Cheng C; Comperat E; Dinney C; Otto W; Shah J; Thürof J; Witjes JA;
    Eur Urol; 2013 Jan; 63(1):36-44. PubMed ID: 22981672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated Detection and Grading of Non-Muscle-Invasive Urothelial Cell Carcinoma of the Bladder.
    Jansen I; Lucas M; Bosschieter J; de Boer OJ; Meijer SL; van Leeuwen TG; Marquering HA; Nieuwenhuijzen JA; de Bruin DM; Savci-Heijink CD
    Am J Pathol; 2020 Jul; 190(7):1483-1490. PubMed ID: 32283104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of receptor activator of nuclear factor kappa B ligand in bladder cancer.
    Ohtaka M; Kawahara T; Ishiguro Y; Sharma M; Yao M; Miyamoto H; Uemura H
    Int J Urol; 2018 Oct; 25(10):901-902. PubMed ID: 30041283
    [No Abstract]   [Full Text] [Related]  

  • 19. Reappraisal of the papillary urothelial neoplasm of low malignant potential (PUNLMP).
    Jones TD; Cheng L
    Histopathology; 2020 Oct; 77(4):525-535. PubMed ID: 32562556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External validation of EORTC risk scores to predict recurrence after transurethral resection of brazilian patients with non -muscle invasive bladder cancer stages Ta and T1.
    Almeida GL; Busato WF; Ribas CM; Ribas JM; De Cobelli O
    Int Braz J Urol; 2016; 42(5):932-941. PubMed ID: 27509372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.